174 related articles for article (PubMed ID: 24381053)
1. A SAR and QSAR study of new artemisinin compounds with antimalarial activity.
Santos CB; Vieira JB; Lobato CC; Hage-Melim LI; Souto RN; Lima CS; Costa EV; Brasil DS; Macêdo WJ; Carvalho JC
Molecules; 2013 Dec; 19(1):367-99. PubMed ID: 24381053
[TBL] [Abstract][Full Text] [Related]
2. A study on antimalarial artemisinin derivatives using MEP maps and multivariate QSAR.
Cardoso FJ; de Figueiredo AF; da Silva Lobato M; de Miranda RM; de Almeida RC; Pinheiro JC
J Mol Model; 2008 Jan; 14(1):39-48. PubMed ID: 17968600
[TBL] [Abstract][Full Text] [Related]
3. Rational Design of Antimalarial Drugs Using Molecular Modeling and Statistical Analysis.
Santos CB; Lobato CC; Braga FS; Costa Jda S; Favacho HA; Carvalho JC; Macedo WJ; Brasil Ddo S; Silva CH; Silva Hage-Melim LI
Curr Pharm Des; 2015; 21(28):4112-27. PubMed ID: 26017698
[TBL] [Abstract][Full Text] [Related]
4. Role of 2-Dimensional Autocorrelation Descriptors in Predicting Antimalarial Activity of Artemisinin and its Aanalogues: A QSAR Study.
Kalra S; Joshi G; Kumar R; Munshi A
Curr Top Med Chem; 2018; 18(31):2720-2730. PubMed ID: 30659538
[TBL] [Abstract][Full Text] [Related]
5. QSAR, docking and ADMET studies of artemisinin derivatives for antimalarial activity targeting plasmepsin II, a hemoglobin-degrading enzyme from P. falciparum.
Qidwai T; Yadav DK; Khan F; Dhawan S; Bhakuni RS
Curr Pharm Des; 2012; 18(37):6133-54. PubMed ID: 22670592
[TBL] [Abstract][Full Text] [Related]
6. A QSAR, pharmacokinetic and toxicological study of new artemisinin compounds with anticancer activity.
Vieira JB; Braga FS; Lobato CC; Santos CF; Costa JS; Bittencourt JA; Brasil DS; Silva JO; Hage-Melim LI; Macêdo WJ; Carvalho JC; Santos CB
Molecules; 2014 Jul; 19(8):10670-97. PubMed ID: 25061720
[TBL] [Abstract][Full Text] [Related]
7. Molecular docking and 3-D-QSAR studies on the possible antimalarial mechanism of artemisinin analogues.
Cheng F; Shen J; Luo X; Zhu W; Gu J; Ji R; Jiang H; Chen K
Bioorg Med Chem; 2002 Sep; 10(9):2883-91. PubMed ID: 12110308
[TBL] [Abstract][Full Text] [Related]
8. The role of charge distribution on the antimalarial activity of artemisinin analogues.
Rafiee MA; Hadipour NL; Naderi-manesh H
J Chem Inf Model; 2005; 45(2):366-70. PubMed ID: 15807501
[TBL] [Abstract][Full Text] [Related]
9. QSAR Study of Artemisinin Analogues as Antimalarial Drugs by Neural Network and Replacement Method.
Abbasitabar F; Zare-Shahabadi V
Drug Res (Stuttg); 2017 Aug; 67(8):476-484. PubMed ID: 28561237
[TBL] [Abstract][Full Text] [Related]
10. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
[TBL] [Abstract][Full Text] [Related]
11. Development predictive QSAR models for artemisinin analogues by various feature selection methods: a comparative study.
Abbasitabar F; Zare-Shahabadi V
SAR QSAR Environ Res; 2012 Jan; 23(1-2):1-15. PubMed ID: 22040327
[TBL] [Abstract][Full Text] [Related]
12. Molecular modelling based target identification for endo-peroxides class of antimalarials.
Gupta AK; Saxena AK
Comb Chem High Throughput Screen; 2015; 18(2):199-207. PubMed ID: 25543685
[TBL] [Abstract][Full Text] [Related]
13. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
[TBL] [Abstract][Full Text] [Related]
14. Homology modeling and molecular docking study of translationally controlled tumor protein and artemisinin.
Chae J; Choi I; Kim C
Arch Pharm Res; 2006 Jan; 29(1):50-8. PubMed ID: 16491843
[TBL] [Abstract][Full Text] [Related]
15. Quantitative structure-activity relationships of the antimalarial agent artemisinin and some of its derivatives - a DFT approach.
Rajkhowa S; Hussain I; Hazarika KK; Sarmah P; Deka RC
Comb Chem High Throughput Screen; 2013 Sep; 16(8):590-602. PubMed ID: 23597248
[TBL] [Abstract][Full Text] [Related]
16. Quantitative structure-activity relationship and molecular docking of artemisinin derivatives to vascular endothelial growth factor receptor 1.
Saeed ME; Kadioglu O; Seo EJ; Greten HJ; Brenk R; Efferth T
Anticancer Res; 2015 Apr; 35(4):1929-34. PubMed ID: 25862844
[TBL] [Abstract][Full Text] [Related]
17. The binding modes and binding affinities of artemisinin derivatives with Plasmodium falciparum Ca2+-ATPase (PfATP6).
Naik PK; Srivastava M; Bajaj P; Jain S; Dubey A; Ranjan P; Kumar R; Singh H
J Mol Model; 2011 Feb; 17(2):333-57. PubMed ID: 20461426
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships of the antimalarial agent artemisinin. 8. design, synthesis, and CoMFA studies toward the development of artemisinin-based drugs against leishmaniasis and malaria.
Avery MA; Muraleedharan KM; Desai PV; Bandyopadhyaya AK; Furtado MM; Tekwani BL
J Med Chem; 2003 Sep; 46(20):4244-58. PubMed ID: 13678403
[TBL] [Abstract][Full Text] [Related]
19. Modeling of peroxide activation in artemisinin derivatives by serial docking.
Little RJ; Pestano AA; Parra Z
J Mol Model; 2009 Jul; 15(7):847-58. PubMed ID: 19142675
[TBL] [Abstract][Full Text] [Related]
20. Conversion of antimalarial drug artemisinin to a new series of tricyclic 1,2,4-trioxanes1.
Singh C; Chaudhary S; Kanchan R; Puri SK
Org Lett; 2007 Oct; 9(21):4327-9. PubMed ID: 17877363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
